All filters
Slidesets
Biological Insights Taught by Clinical Responses to Novel Hbv-Hdv Drugs - S. Urban, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation - P. Mishra, MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
How to Handle Flares in HBV Trials With Novel Agents - Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBsAg Loss. A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
A Novel Approach At Targeting the PD-1PD-l1 Pathway - PD-l1 Lna - A
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci
Presented at:
International Workshop on HBV Cure 2021
Slidesets
VBI-2601 Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Immunotherapeutics in the Treatment of Chronic Hepatatis B - S. Browne, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Anti-HBs Antibody - C. Hwang, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
What Can We Learn by Deploying Immunological Analysis in Phase II Clinical Trials - A. Gehring, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Patient Selection for Clinical Trials Based on Drug Class - F. Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
New Data From Combination Trials for Chronic Hepatitis B - P. Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
New Combination Therapies in Hepatitis Delta Therapy - J. Glenn, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Novel Drug Delivery Systems on the Horizon - Charles Flexner, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Whatever Happened with PEP - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipGUM, DFSRH
Presented at:
HIV Prevention Summit 2021
Slidesets
Successful Models of PrEP Implementation - François Venter, MD, FCP, PhD
Presented at:
HIV Prevention Summit 2021
Slidesets
Successes to Access PrEP and PEP End-User Perspective - Gcobisa Madlolo
Presented at:
HIV Prevention Summit 2021
Slidesets
The Prevention Pipeline and Clinical Trial Design for PrEP - Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Presented at:
HIV Prevention Summit 2021
Slidesets
Why Don't Prescribers Prescribe - Douglas Krakower, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Overview of Clinical Data on the Safety and Efficacy of Antiretroviral Drugs for HIV Prevention - Roy M. Gulick, MD, MPH
Presented at:
HIV Prevention Summit 2021
Slidesets
WHO Perspective on HIV Prevention - What Are the Gaps - Rachel Baggaley, MBBS, MSc
Presented at:
HIV Prevention Summit 2021
Slidesets
Antibody Mediated Prevention of HIV - Myron S. Cohen, MD, BS
Presented at:
HIV Prevention Summit 2021
Slidesets
Socio-Demographics of Individuals Initiated on HIV pre-exposure prophylaxis (PrEP) in Nigeria - Augustine Idemudia
Presented at:
HIV Prevention Summit 2021